181 related articles for article (PubMed ID: 16261676)
1. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):993-7. PubMed ID: 16261676
[TBL] [Abstract][Full Text] [Related]
2. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):438-42. PubMed ID: 15821963
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
Kurata C; Okayama K; Wakabayashi Y; Shouda S; Mikami T; Tawarahara K; Sugiyama T
J Nucl Med; 1997 Nov; 38(11):1677-80. PubMed ID: 9374332
[TBL] [Abstract][Full Text] [Related]
4. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Kiyono Y; Iida Y; Kawashima H; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med; 2001 Jul; 28(7):894-9. PubMed ID: 11504086
[TBL] [Abstract][Full Text] [Related]
5. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
[TBL] [Abstract][Full Text] [Related]
6. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
7. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
[TBL] [Abstract][Full Text] [Related]
8. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.
Verberne HJ; de Bruin K; Habraken JB; Somsen GA; Eersels JL; Moet F; Booij J; van Eck-Smit BL
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):483-90. PubMed ID: 16425032
[TBL] [Abstract][Full Text] [Related]
9. Effect of an aldose reductase inhibitor on altered sympathetic nerve responsiveness of isolated right atria in diabetic rats.
Sato N; Hashimoto H; Takiguchi Y; Nakashima M
Arzneimittelforschung; 1990 Jul; 40(7):763-6. PubMed ID: 2121149
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
11. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
Dubois EA; Kam KL; Somsen GA; Boer GJ; de Bruin K; Batink HD; Pfaffendorf M; van Royen EA; van Zwieten PA
Eur J Nucl Med; 1996 Aug; 23(8):901-8. PubMed ID: 8753678
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes.
Schmid H; Forman LA; Cao X; Sherman PS; Stevens MJ
Diabetes; 1999 Mar; 48(3):603-8. PubMed ID: 10078563
[TBL] [Abstract][Full Text] [Related]
13. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats.
Soltesova Prnova M; Ballekova J; Gajdosikova A; Gajdosik A; Stefek M
Physiol Res; 2015; 64(4):587-91. PubMed ID: 26291727
[TBL] [Abstract][Full Text] [Related]
14. I-123 MIBG cardiac imaging in diabetic neuropathy before and after epalrestat therapy.
Utsunomiya K; Narabayashi I; Nakatani Y; Tamura K; Onishi S
Clin Nucl Med; 1999 Jun; 24(6):418-20. PubMed ID: 10361937
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
[TBL] [Abstract][Full Text] [Related]
16. Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes.
Goethals LR; Weytjens CD; De Geeter F; Droogmans S; Caveliers V; Keyaerts M; Vanhove C; Van Camp G; Bossuyt A; Lahoutte T
Contrast Media Mol Imaging; 2009; 4(4):174-82. PubMed ID: 19672853
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sympathetic nerve function assessed by [131I]metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs.
Takatsu H; Duncker CM; Arai M; Becker LC
J Nucl Cardiol; 1997; 4(1 Pt 1):35-41. PubMed ID: 9138838
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin attenuates diabetes-induced cardiac sympathetic neuropathy in association with a decrease in oxidative stress.
Matsuki A; Nozawa T; Igarashi N; Sobajima M; Ohori T; Suzuki T; Fujii N; Igawa A; Inoue H
Circ J; 2010 Mar; 74(3):468-75. PubMed ID: 20103973
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.
Nomura Y; Matsunari I; Takamatsu H; Murakami Y; Matsuya T; Taki J; Nakajima K; Nekolla SG; Chen WP; Kajinami K
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):871-8. PubMed ID: 16721572
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging.
Kiyono Y; Kanegawa N; Kawashima H; Iida Y; Kinoshita T; Tamaki N; Nishimura H; Ogawa M; Saji H
Nucl Med Biol; 2002 Aug; 29(6):679-84. PubMed ID: 12234593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
